The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of MTAP deletion on immunotherapy outcomes in patients with mesothelioma.
 
Jessica Ross
No Relationships to Disclose
 
Eduardo Ortiz
No Relationships to Disclose
 
Gustavo Barraza
No Relationships to Disclose
 
Maria Mayoral
No Relationships to Disclose
 
Michelle Ginsberg
No Relationships to Disclose
 
Alexandra Luongo
No Relationships to Disclose
 
Andrea Arfe
No Relationships to Disclose
 
Marjorie Zauderer
Honoraria - Medscape
Consulting or Advisory Role - AstraZeneca/MedImmune; Orion; Roche Molecular Diagnostics
Research Funding - Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Merck (Inst); Millennium (Inst); Polaris (Inst); Sapience Therapeutics (Inst); Sellas Life Sciences (Inst); Vivace Therapeutics (Inst); Werewolf Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation
 
Prasad Adusumilli
Consulting or Advisory Role - Atara Biotherapeutics; Bayer; BioArdis; Carisma Therapeutics; ImmPACT-Bio; Imugene; Orion; Outpace Bio
Research Funding - Atara Biotherapeutics
Patents, Royalties, Other Intellectual Property - Atara Biotherapeutics
 
Scott Eckert
No Relationships to Disclose
 
Matteo Repetto
No Relationships to Disclose
 
Soo-Ryum Yang
Honoraria - AstraZeneca; Medical Learning Institute; Medscape; OncLive/MJH Life Sciences; Prime Education; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; InVitae; Merus; Sanofi
(OPTIONAL) Uncompensated Relationships - Boehringer Ingelheim; Loxo/Lilly
 
Maelle Saliba
No Relationships to Disclose
 
Jennifer Sauter
Stock and Other Ownership Interests - Chemed; Merck; Pfizer; Thermo Fisher Scientific
Consulting or Advisory Role - Vivace Therapeutics
Travel, Accommodations, Expenses - DAVA Oncology
 
Gregory Riely
Honoraria - Dava Oncology
Research Funding - Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Patent application submitted covering pulsatile use of erlotinib to treat or prevent brain metastases (Inst)
Travel, Accommodations, Expenses - Bayer; Merck
Other Relationship - Mirati Therapeutics; Pfizer; Roche/Genentech; Takeda
 
Kathryn Arbour
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genzyme; Lilly; Merck; Novartis; Regeneron; Revolution Medicines; Sanofi
Research Funding - Bristol Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Revolution Medicines (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb; Revolution Medicines
 
Mark Kris
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex; Daiichi Sankyo/Astra Zeneca; Merck; Pfizer; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Genentech
 
Marc Ladanyi
Stock and Other Ownership Interests - PAIGE.AI
Consulting or Advisory Role - ADC Therapeutics; Bayer Health; Bayer Health; Gilead Sciences; Merck; MSD
Research Funding - ADC Therapeutics (Inst); Elevation Oncology (Inst); Helsinn Therapeutics (Inst); Merus NV (Inst); Rain Therapeutics
Patents, Royalties, Other Intellectual Property - Royalties from a license agreement between MSK and Sophia Genetics
 
Michael Offin
Honoraria - OncLive
Consulting or Advisory Role - American Society for Radiation Oncology; Jazz Pharmaceuticals; Novartis; Pfizer; PharmaMar; Targeted Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
(OPTIONAL) Uncompensated Relationships - Mesothelioma Applied Research Foundation